Ingenza Celebrates EU H2020 SME Instrument Success
News Aug 17, 2016

Ingenza is pleased to announce it has successfully applied for EU H2020 SME Instrument funding of €50,000 for Phase 1 of its innovative SYNBIOMAN project, allowing the company to forge ahead with the development of this novel synthetic biology-driven biomanufacturing platform. Successful completion of the Phase 1 study could open the door to additional funding for Phase 2, valued at €2.5 million.
SYNBIOMAN will build on Ingenza’s proprietary industrial synthetic and systems biology tools, helping small and medium-sized biotechnology enterprises to close the gap from lab to market by developing GMP biomanufacturing capabilities that target the production of therapeutic proteins. Frequently, these drug candidates are sourced from low yielding organisms, have highly complex structures, or are very toxic. As a result, they can be challenging to manufacture, preventing the development of new therapies for currently unmet clinical needs. Dr David McElroy, Chief Business Officer at Ingenza, said: “We are delighted to have secured EU H2020 SME Instrument support for this project. The Horizon 2020 programme receives thousands of funding applications each year, and fewer than five per cent of applicants are successful. It is a real achievement for our scientific research to be recognised in this way.”
RELATED ARTICLES
DNA Barcodes Help Track Cells
NewsEach of our genomes contains millions of one-letter variations called single nucleotide polymorphisms. Researchers have now developed a technique that utilizes these unique features to track cells from different donors.
READ MORENon-Coding DNA Variants Increase Autism Risk
NewsWhilst the contribution of gene variants to autism risk is well-established, the contribution of the 98% of the genome that does not code for gene sequences is still relatively unknown. Now, a new study has identified regulatory elements as potential genetic risk factors.
READ MOREPoop Helps Track Hybrid Monkey Mating
NewsOn the shores of Lake Tanganyika in Tanzania, Gombe National Park hosts diverse populations of guenon monkeys. A study examining mitochondrial DNA left in their poop has revealed unexpected insight into how these monkeys mate.
READ MOREComments | 0 ADD COMMENT
Like what you just read? You can find similar content on the communities below.
Genomics ResearchTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE15th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry
Sep 09 - Sep 12, 2018
CE in the Biotechnology & Pharmaceutical Industries: 20th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides & Small Molecules
Sep 09 - Sep 12, 2018
Login
You must be logged in to post a comment.